Status:
COMPLETED
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
Lead Sponsor:
Shaheed Zulfiqar Ali Bhutto Medical University
Conditions:
Hemangioma
Propranolol
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Infantile hemangiomas are widespread vascular tumours having incidence of 10% and most of them involute spontaneously. However, they are known to be located in proximity of vital organs and can have p...
Detailed Description
Material \& Methods Study design: Randomised controlled trial Place of study: This is study was conducted in the department of paediatric surgery, children hospital, Pakistan institute of medical scie...
Eligibility Criteria
Inclusion
- 1\. 6 month to 12 yr. of age presenting with infantile hemangioma anywhere on body 2. Both sex included 3. Previously not treated
Exclusion
- On the basis of history and clinical assessment;
- Patients with previous treatment of hemangioma.
- Patients who will be lost to follow up
- Patients who refused to be enrolled in this study
- Patients who experienced hypersensitivity to propranolol/Bleomycin during treatment or had previous known allergy to the drugs.
- Patients who had diagnosed Cardiac disease such as heart failure or AV block.
- Patients with diagnosed Pulmonary disease such as asthma or bronchiolitis.
- History of impaired renal or liver functions.
- Diabetes mellitus
- \-
Key Trial Info
Start Date :
May 8 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05327309
Start Date
May 8 2015
End Date
January 1 2018
Last Update
September 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.